Sotera Health vs Tempus AI
Add, change or remove companies; up to four.
The short version
- Tempus AI is the larger business, with $1.3B of revenue in fiscal 2025 against $1.2B for Sotera Health.
- Tempus AI grew revenue faster (83.4%, against 5.7%).
- Sotera Health turned more of its sales into free cash flow (12.8% FCF margin, against β18.8%).
| Latest fiscal year | SHC Β· FY25 | TEM Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $5.2B | $13.5M |
| Revenue | $1.2B | $1.3B |
| Free cash flow | $149M | β$239M |
| Net income | $77.9M | β$245M |
| Growth | ||
| Revenue growth | 5.7% | 83.4% |
| 5-year growth | 7.3% | β |
| Share count change | 0.5% | 45.4% |
| Profitability | ||
| Gross margin | 55.5% | β |
| Operating margin | β | β19.9% |
| Net margin | 6.7% | β19.3% |
| FCF margin | 12.8% | β18.8% |
| Return on capital | 6.7% | β |
| Return on equity | 15.4% | β89.5% |
| Balance sheet | ||
| Net debt | $1.9B | β$396M |
| Net debt / EBITDA | β | β |
| Dividends and buybacks | $0.0M | $3.0M |
| Valuation & quality | ||
| P/E | 31.8x | β |
| Piotroski F-score | 7 | 5 |
FY19
SHC $778M
TEM β
FY20
SHC $818M
TEM β
FY21
SHC $932M
TEM β
FY22
SHC $1.0B
TEM $321M
FY23
SHC $1.0B
TEM $532M
FY24
SHC $1.1B
TEM $693M
FY25
SHC $1.2B
TEM $1.3B
SHC
TEM
FY19
SHC 23.6%
TEM β
FY20
SHC 25.2%
TEM β
FY21
SHC 27.6%
TEM β
FY22
SHC 24.7%
TEM β82.8%
FY23
SHC 26.4%
TEM β36.9%
FY24
SHC 27.1%
TEM β99.7%
FY25
SHC β
TEM β19.9%
SHC
TEM
FY19
SHC $91.8M
TEM β
FY20
SHC $67.1M
TEM β
FY21
SHC $179M
TEM β
FY22
SHC $95.6M
TEM β$187M
FY23
SHC β$363M
TEM β$249M
FY24
SHC $45.1M
TEM β$211M
FY25
SHC $149M
TEM β$239M
SHC
TEM
FY19
SHC β
TEM β
FY20
SHC β
TEM β
FY21
SHC 7.6%
TEM β
FY22
SHC 9.3%
TEM β
FY23
SHC 6.3%
TEM β
FY24
SHC 6.1%
TEM β
FY25
SHC 6.7%
TEM β
SHC
TEM
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.